Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Neurology | Oncology

Brain Metastases Clinical Trials

A listing of Brain Metastases medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.

Alabama

University of Alabama at Birmingham/ Kirklin Clinic Univ AL - PI
Birmingham Alabama 35294-0006

A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+

University Of Alabama at Birmingham
Birmingham Alabama 35294

A Phase 2 clinical study for patients with HER-2 Positive Breast Cancer

Arkansas

Highlands Oncology Group Dept of Highlands Oncology Grp
Fayetteville Arkansas 72703

A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+

Florida

Memorial Regional Cancer Center Memorial Breast
Hollywood Florida 33021

A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+

MD Anderson Cancer Center- Orlando
Orlando Florida 32806

A Phase 2 clinical study for patients with HER-2 Positive Breast Cancer

Illinois

University Of Chicago Medical Center
Chicago Illinois 60637

A Phase 2 clinical study for patients with HER-2 Positive Breast Cancer

Ingalls Memorial Hospital Ingalls Mem Hosp
Harvey Illinois 60426

A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+

Maryland

NCI
Rockville Maryland 20892
Updated

Patients are needed to participate in a clinical research study of GRN1005 and Trastuzumab to evaluate Breast Cancer or Brain Metastases

Massachusetts

Beth Israel Deaconess Medical Center
Boston Massachusetts 02115

A Phase 2 clinical study for patients with Brain Metastases or Solid Tumors

Dana-Farber Cancer Institute
Boston Massachusetts 02115

A Phase 2 clinical study for patients with Brain Metastases or Solid Tumors

Missouri

Washington University School Of Medicine-Siteman Cancer Ctr WA Siteman
St. Louis Missouri 63110

A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+

New York

Beth Israel Medical Center BIMC
New York New York 10003

A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+

Department of Radiation oncology, Memorial Sloan Kettering Cancer Center
New York New York 10065

A Phase 2 clinical study for patients with Brain Metastases or Solid Tumors

Memorial Sloan Kettering Cancer Center
New York New York 10065

Patients are needed to participate in a clinical research study evaluating Whole Brain Radiotherapy (WBRT) and Sorafenib for the treatment of Breast Cancer or Brain Metastases

North Carolina

UNC Lineberger Comprehensive Cancer Center
Chapel Hill North Carolina 27599

A Phase 2 clinical study for patients with HER-2 Positive Breast Cancer

UNC Lineberger Comprehensive Cancer Center
Chapel Hill North Carolina 27599
Updated

Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks

Duke University Medical Center Duke South 2
Durham North Carolina 27710

A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+

Kinston Medical Specialists, PA
Kinston North Carolina 28501

A Phase 2 clinical study for patients with HER-2 Positive Breast Cancer

Pennsylvania

UPMC Shadyside Radiation Oncology
Pittsburgh Pennsylvania 15232

A Phase 2 clinical study for patients with Brain Metastases or Solid Tumors

Tennessee

Sarah Cannon Research Institute Sarah Cannon Cancer Center SC
Nashville Tennessee 37203

A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+

Vanderbilt-Ingram Cancer Center
Nashville Tennessee 37212

A Phase 2 clinical study for patients with HER-2 Positive Breast Cancer

Texas

UT MD Anderson Cancer Center
Houston Texas 77030
Updated

Patients are needed to participate in a clinical research study evaluating TPI 287, Dexamethasone, Benadryl and Ranitidine for the treatment of Breast Cancer

Virginia

University of Virginia
Charlottesville Virginia 22903

A Phase 2 clinical study for patients with HER-2 Positive Breast Cancer

Austria

Medical University of Vienna
Vienna

A clinical trial to evaluate treatments using NovoTTF-100A device and Best Standard of Care for patients with 1-3 Brain Metastases From Non-Small Cell Lung Cancer

Belgium

Universitair Ziekenhuis Antwerpen
Antwerp B-2650
Updated

Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks

Jules Bordet Institute
Brussels B-1000
Updated

Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks

Novartis Investigative Site
Liege 4000

A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+

Novartis Investigative Site
Wilrijk 2610

A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+

China

West China Hospital
Chengdu Sichuan 610041

A clinical research study of icotinib and Whole brain radiotherapy for the treatment of Non-small Cell Lung Cancer or Brain Metastases

The First People's Hospital of Lianyungang
Lianyungang Jiangsu 222002

Patients are needed to participate in a clinical research study of 6MV-X ray and Endostar to evaluate Brain Metastases

Czech Republic

Na Homolce Hospital
Prague

A clinical trial to evaluate treatments using NovoTTF-100A device and Best Standard of Care for patients with 1-3 Brain Metastases From Non-Small Cell Lung Cancer

France

Institut Curie
Paris Paris Cedex 05 75248
Updated

Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks

Israel

Tel Aviv Sourasky Medical Center
Tel Aviv 64239

A clinical trial to evaluate treatments using NovoTTF-100A device and Best Standard of Care for patients with 1-3 Brain Metastases From Non-Small Cell Lung Cancer

Italy

Ospedale Lecco
Lecco

A clinical trial to evaluate treatments using NovoTTF-100A device and Best Standard of Care for patients with 1-3 Brain Metastases From Non-Small Cell Lung Cancer

Novartis Investigative Site
Modena MO 41100

A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+

Netherlands

Antoni van Leeuwenhoek Ziekenhuis
Amsterdam 1066 CX
Updated

Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks

Vrije Universiteit medisch centrum (Vumc)
Amsterdam 1081 HV
Updated

Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks

Leids Universitair Medisch Centrum (LUMC)
Leiden 2333 CA
Updated

Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks

Maastricht Universitair Medisch Centrum
Maastricht 6229 HX
Updated

Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks

Erasmus MC
Rotterdam 3075 EA
Updated

Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks

Spain

Novartis Investigative Site
Barcelona Cataluna 08035

A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+

Novartis Investigative Site
Hospitalet de LLobregat Catalunya 08907

A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+

Novartis Investigative Site
Valencia Comunidad Valenciana 46010

A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+

United Kingdom

Novartis Investigative Site
Brighton East Sussex BN2 5BE

A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+

Novartis Investigative Site
Nottingham NG5 1PB

A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+

Novartis Investigative Site
Oxford OX3 7LJ

A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+